Author Archives: Natalie Themm
BD Names William ‘Bill’ Brown to Board of Directors
BD Names William ‘Bill’ Brown to Board of Directors
DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection; improvements were sustained at the one-year interim readout with additional data to follow at 18 and 24 months.
Merit Medical rises on Street-beating Q4, sets 2022 guidance
Merit Medical shares were up today on fourth-quarter results that topped the consensus forecast.
Civica to Manufacture and Distribute Affordable Insulin
Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model
MDMA Urgent Request: Medical Supplies for Ukraine Needed
MDMA Urgent Request: Medical Supplies for Ukraine Needed
ARUP Renames Consulting Team as ARUP Healthcare Advisory Services
ARUP Laboratories has renamed its expert team of healthcare consultants as ARUP Healthcare Advisory Services.
TRIA Transcatheter Biopolymer Heart Valve Shows Promise in Pilot Animal Study
Foldax announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio
BD Appoints Shana Neal as Chief People Officer
BD announced that Shana Neal has been appointed chief people officer.
Volunteer Opportunities for Weber County STEM events
Volunteers Needed for Weber County STEM events
Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
Myriad Genetics announced financial results for its fourth quarter and year ended Dec. 31, 2021.
SINTX ANNOUNCES MILESTONES IN THE DEVELOPMENT AND TESTING OF ANTIPATHOGENIC FABRICS
SINTX Technologies announced new results on the development of manufacturing technologies to produce fabrics impregnated with SINTX silicon nitride, and the antipathogenic testing of these fabrics.
